M'sia to deliberate on AstraZeneca vaccine over 'very rare' blood clots link
Published
Modified5:37 am
-
The Covid-19 vaccine committee will deliberate on whether to use the AstraZeneca vaccine after European Union Regulators found a link between it and "very rare" cases of blood clots.
"The committee will deliberate on the matter and decide if we will go ahead with using AstraZeneca in our portfolio of vaccines.
"Safety is paramount," said
All Access Plan